Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer

7 Mar 2018

Abstract excerpt

Abstract Purpose: The current tumor–node–metastasis (TNM) staging system is inadequate at identifying patients with high-risk colorectal cancer. Using a systematic and comprehensive biomarker discovery and validation approach, we aimed to identify an miRNA recurrence classifier (MRC) that can improve upon the current TNM staging as well as is superior to currently offered molecular assays. Experimental Design:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to Colorectal Cancer Treatments and Studies
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29514841
DOI: 10.1158/1078-0432.ccr-17-3236

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal CancerPMID 29514841Read ↗

Genome‐wide identification of a novel mi RNA ‐based signature to predict recurrence in patients with gastric cancerSemantic proximity Read ↗

Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stages I-III colorectal cancerSemantic proximity Read ↗

Recurrence‐associated gene signature optimizes recurrence‐free survival prediction of colorectal cancerSemantic proximity Read ↗

Using ctDNA to Predict Recurrence After Surgery in Stage II–III Colorectal Cancer: A Systematic Review and Narrative Meta-AnalysisSemantic proximity Read ↗

Cross-Cohort Evaluation of NanoString nCounter Data for Recurrence Prediction in Colorectal CancerSemantic proximity Read ↗

A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancerSemantic proximity Read ↗

Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer.Semantic proximity Read ↗

Exploration of predictive biomarkers for postoperative recurrence of stage II/III colorectal cancer using genomic sequencing.Semantic proximity Read ↗

Transcriptomic profiling reveals an enhancer RNA signature for recurrence prediction in colorectal cancerSemantic proximity Read ↗

A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.Semantic proximity Read ↗

A network‐based predictive gene expression signature for recurrence risks in stage II colorectal cancerSemantic proximity Read ↗

Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.